Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
157.21
-1.21 (-0.76%)
At close: May 18, 2026, 4:00 PM EDT
157.51
+0.30 (0.19%)
Pre-market: May 19, 2026, 6:52 AM EDT

Neurocrine Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
15,80714,19713,56813,00511,5268,083
Market Cap Growth
44.55%4.64%4.33%12.83%42.60%-9.81%
Enterprise Value
14,95513,13212,94712,23110,6307,812
Last Close Price
157.21141.83136.50131.76119.4485.17
PE Ratio
24.1830.3741.4953.3476.5692.58
Forward PE
14.0615.8718.1521.3422.5324.55
PEG Ratio
0.330.750.310.650.370.37
PS Ratio
5.104.965.766.897.747.13
PB Ratio
4.644.365.245.836.755.88
P/TBV Ratio
4.744.475.475.966.926.07
P/FCF Ratio
19.0218.9624.3535.9635.7034.67
P/OCF Ratio
18.3018.1422.7933.3533.9631.51
EV/Sales Ratio
4.824.595.506.487.146.89
EV/EBITDA Ratio
18.0520.2321.6744.9440.1768.89
EV/EBIT Ratio
18.7221.2122.6948.7542.6976.21
EV/FCF Ratio
17.9917.5423.2433.8332.9233.51
Debt / Equity Ratio
0.120.130.180.120.050.32
Debt / EBITDA Ratio
0.500.640.761.570.993.88
Debt / FCF Ratio
0.490.560.821.190.811.89
Net Debt / Equity Ratio
-0.27-0.33-0.24-0.27-0.42-0.20
Net Debt / EBITDA Ratio
-1.11-1.64-1.04-2.22-2.74-2.39
Net Debt / FCF Ratio
-1.09-1.42-1.11-1.67-2.25-1.16
Asset Turnover
0.650.690.680.670.670.60
Inventory Turnover
0.850.820.711.080.710.49
Quick Ratio
2.512.923.062.252.493.65
Current Ratio
2.933.393.402.452.703.96
Return on Equity (ROE)
20.08%16.38%14.16%12.68%10.03%7.17%
Return on Assets (ROA)
11.80%10.06%11.50%6.71%8.10%4.76%
Return on Invested Capital (ROIC)
21.26%18.04%20.28%13.46%16.60%9.53%
Return on Capital Employed (ROCE)
19.82%17.44%19.65%11.33%13.62%6.07%
Earnings Yield
4.23%3.29%2.41%1.87%1.31%1.08%
FCF Yield
5.26%5.27%4.11%2.78%2.80%2.88%
Buyback Yield / Dilution
0.68%1.16%-2.67%-2.12%-1.02%-0.10%
Total Shareholder Return
0.68%1.16%-2.67%-2.12%-1.02%-0.10%
Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q